Cardiovascular Health Supplements Market Report Size Analysis:

The cardiovascular health supplements market size was valued at USD 11.32 billion in 2024 and is expected to reach USD 20.31 billion by 2032, growing at a CAGR of 7.62% over the forecast period of 2025-2032.

The cardiovascular health supplements market is witnessing consistent growth due to growing cardiovascular disease incidence and rising awareness about preventive healthcare. Consumers are increasingly turning to supplements such as omega-3 fatty acids, CoQ10, and plant sterols to promote heart health. The cardiovascular health supplements market trends toward natural and functional nutrition, combined with the aging population globally, are also driving demand. Distribution via the internet, ingredient innovation, and clinical evidence to support ingredients are also helping expand markets throughout developed and emerging nations.

The U.S. cardiovascular health supplements market size was valued at USD 2.24 billion in 2024 and is expected to reach USD 4.14 billion by 2032, growing at a CAGR of 8.06% over the forecast period of 2025-2032. The U.S has a leading position in North America's cardiovascular health supplements companies, courtesy of a high incidence of cardiovascular diseases, an aging population, and high awareness of preventive healthcare. The popularity of brands such as omega-3 fatty acids, CoQ10, and plant sterols also supports the dominance of their presence in the region.

For Instance, in September 2023, in September 2023, Chile-based supplement manufacturer Nutrartis introduced to the U.S. market Cardiosmile, a liquid sachet plant sterol water-dispersible supplement designed to support cardiovascular health. This innovative delivery form is an effortless way for consumers to add heart-healthy sterols to their diet simply by adding the product to water, food, or drinks.

Cardiovascular Health Supplements Market Dynamics

Drivers

  • The Increasing Incidence of Cardiovascular Diseases (CVDs) is Driving the Market Growth

The incidence of cardiovascular diseases, such as heart attacks, hypertension, stroke, and coronary artery disease, has been progressively rising globally due to reasons such as sedentary lifestyle, excessive consumption of processed foods, smoking, alcoholism, and increased obesity. For instance, as per the World Health Organization (WHO), CVDs are the major killers globally, claiming about 17.9 million lives annually. This increase in cardiovascular disorders has made consumers look for preventive measures, including dietary supplements that help promote heart health. Supplements of omega-3 fatty acids, CoQ10, and plant sterols are becoming more popular as everyday habits to lower cardiovascular risk factors such as high cholesterol and blood pressure.

  • Increasing Geriatric Population is Propelling the Market Growth

The world's aging population is a major catalyst for the cardiovascular health supplements market analysis. As people age, they become increasingly susceptible to cardiovascular disease due to arterial stiffness, decreased metabolism, and variations in cholesterol and blood pressure levels. The United Nations estimates that by 2050, the number of people aged 60 years and older will double to more than 2 billion. This elderly population is healthier and more likely to include supplements as part of their preventive healthcare routine. Consequently, the demand for heart-friendly products tailored to the elderly is on the rise, driving the cardiovascular health supplements market growth in the developed and emerging markets.                                

Restraint

  • The Expensive Price of Premium Supplements is Restraining the Market Growth

High-end cardiovascular health supplements, such as those that contain purified omega-3 fatty acids, Coenzyme Q10 (CoQ10), and plant sterols, are likely to command a premium price due to their clinically proven ingredients and cutting-edge formulations. For instance, the LYMA supplement has attracted interest due to its synergistic formulation for addressing overall health, including cardiovascular wellness. Although such products have the potential to provide health benefits, their expense can be a barrier for many consumers, especially in low- and middle-income households. This price sensitivity limits wider adoption, particularly in areas without insurance coverage or reimbursement policies for dietary supplements.

Cardiovascular Health Supplements Market Segmentation Analysis

By Type

In 2024, the market was dominated by the natural supplements segment, with a market share of more than 72% in the world. This is attributed to increasing customer demand for products that are made from plants and organic substances that are also perceived as being holistically healthier and safer compared to synthesized products. Natural supplements, which are mostly obtained from herbal extracts, marine extracts, and whole foods, undergo less processing than other supplements. They also adhere to wellness-centered lifestyles. The growing realization of the significance of wellness and health has encouraged customers to demand natural remedies instead of traditional pharmaceuticals.

The synthetic supplements segment will grow fastest over the forecast period with a 7.96% CAGR, such growth is fueled by demand for standardized formulations, accurate dosing, and economical manufacturing processes. Synthetic supplements provide precise amounts of nutrients, with consistency and effectiveness, which is highly sought after in clinical environments where accurate supplementation of nutrients is needed. Additionally, growing numbers of clinical trials and research on supplements to aid cardiovascular health are also driving the growth of the segment.

By Ingredient

In 2024, the omega fatty acids segment dominated the cardiovascular health supplements market share with a 28.06%. This is due to the widely documented cardiovascular advantages of omega-3 fatty acids, especially EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid). Scientific research has repeatedly established that these essential fatty acids lower triglyceride levels, reduce blood pressure, and decrease the risk of heart disease. For instance, a June 2022 study published in the Journal of the American Heart Association showed that taking 3 grams of omega-3 fatty acids per day through supplements or diet can lower blood pressure. The public consumer awareness of these benefits, coupled with advice from health agencies, has greatly contributed to the demand for omega fatty acid supplements.

For Instance, Life Extension launched its Omega-3 Fish Oil Gummy Bites, a sugar-free, tropical fruit-flavored, fish oil-based supplement in March 2023. The supplement offers a palatable and convenient alternative to capsules of traditional fish oil. With each gummy providing a robust dose of 300 mg of EPA and 225 mg of DHA, two critical omega-3 fatty acids renowned for their ability to support heart, brain, and joint health.

The herbs & botanicals segment is expected to grow at the fastest rate during the forecast period. This growth is fueled by rising consumer demand for natural and holistic means of maintaining health and wellness. Herbal supplements such as garlic, hawthorn, and green tea extracts have become increasingly popular due to their possible benefits for heart health. For instance, allicin, a natural antioxidant found abundantly in garlic, has been shown to decrease the total and LDL cholesterol levels, inhibit blood clotting, and lower blood pressure levels in hypertensive patients to a great extent. Increased demand for natural and plant-based products, along with increased awareness of their efficiency, is driving the growth of this sector.

By Form

The softgels segment led the market in 2024. Softgels have been known for their improved bioavailability, particularly in omega-3 fatty acids, as they keep delicate oils from oxidizing and enhance the absorption. This makes softgels a premier option for cardiovascular health supplements, particularly those designed for triglyceride lowering and cardiovascular wellness.

The capsules segment will exhibit the fastest growth over the forecast years. Capsules present formulating freedom with a broad range of active ingredients, from herbal extracts through to vitamins and minerals, gaining increasing popularity due to cardiovascular conditions. Consumer pressure is the demand driver for capsules based on people preferring to consume easily swallowable supplements and with a longer shelf-life than other formulations, such as liquid. Capsules also provide scope for accurate, repeat dosages, which further drives popularity.

By Distribution Channel

In 2024, the offline segment dominated the market and held around 78.04% of the market share. This is due to consumers having a preference for buying supplements through physical retailing channels such as pharmacies, health food stores, and supermarkets. These retailers provide the benefit of enabling consumers to visually inspect products before purchase, offering a perception of confidence concerning product quality and genuineness. Also, the availability of experienced personnel in these outlets can provide customized advice and recommendations, adding to the shopping experience of the consumer.

The online segment is expected to grow at the fastest rate over the forecast years, with a 7.91% CAGR. This is due to the increasing desire for the convenience of online shopping, enabling people to browse through a wide variety of cardiovascular health supplements from the comfort of their homes. Online shopping websites provide in-depth product descriptions, customer feedback, and usually a greater variety than brick-and-mortar shops, appealing to the tech-savvy, time-efficient consumers. Additionally, the emergence of direct-to-consumer (D2C) supplement brands and the incorporation of personalized marketing techniques have further increased the popularity of online shopping.

Regional Analysis

Asia Pacific dominated the market with around 40.15% market share in 2024 due to its huge and aging population, developing cardiovascular diseases, and strong cultural preference toward preventive and natural care alternatives. China, India, and Japan have experienced growing consumer awareness of heart health and emerging demand for such supplements as omega-3 fatty acids, traditional herbal extracts, and CoQ10. Furthermore, rising middle-class incomes, urbanization, and active promotion by governments to further promote wellness and nutrition further propel the region's market leadership. The availability of indigenous supplement producers with affordable and regionally popular formulations also importantly supports Asia Pacific's market leadership in this market.

North America is anticipated to exhibit the fastest growth within the global cardiovascular health supplements market, driven by increased health awareness, rising rates of diagnosis for cardiovascular diseases, and a turn towards preventive and personalized healthcare. U.S. and Canadian consumers are increasingly seeking evidence-based supplements to support heart health, promoted by health experts. The growth of e-commerce and online wellness platforms has also improved the accessibility of supplements for a larger number of consumers.

Europe has a significant market share due to its aging population, high level of awareness to prevent cardiovascular disease, and good regulatory systems in place to maintain product quality and safety. Major countries such as Germany, the UK, and France dominate supplement intake led by a proactive lifestyle to maintain heart health and wellness.

Germany leads Europe's cardiovascular health supplements market due to it has such high consumer demand for natural and organic products, based on a developed healthcare system and a high awareness level of healthcare in the country. German customers are increasingly selecting supplements such as omega-3 fatty acids, CoQ10, and plant-based products to preserve cardiovascular health, which reflects an overall trend in the direction of preventive medicine and health. This is backed up by a strong regulatory environment that ensures product quality and safety, which in turn supports consumer trust and market growth.

Latin America and the Middle East & Africa (MEA) are experiencing moderate growth in the cardiovascular health supplements market, owing to increased health awareness and a shift towards preventive care. Growth in supplement consumption is being seen in Brazil and Mexico in Latin America, which is being influenced by an expanding middle class, urbanization, and enhanced cardiovascular health awareness. Economic instability and diverse regulatory requirements pose obstacles to the growth of the market in the region.

Cardiovascular Health Supplements Market Key Players

The cardiovascular health supplements companies are Herbalife Nutrition, Amway, Nature’s Bounty, NOW Foods, GNC Holdings, Nordic Naturals, Bayer, Pfizer, Solgar, Thorne HealthTech, and other players.

Recent Developments in the Cardiovascular Health Supplements Market

  • March 2025 – GNC, the world's leading nutritional supplements company, and its Indian master franchisee, Guardian Healthcare Pvt. Limited (GNC India) has launched GNC Pro Performance 100% Whey + Nitro Surge. This first-of-its-kind, made-in-India protein supplement has been formulated to enhance sports performance and cardiovascular health under its cardio-protective composition.

  • March 2025 – Nordic Naturals introduced its new campaign, "The Power of Omega-3," designed to expand public awareness of omega-3s. The campaign focuses on the fact that these nutrients provide so much more than heart health advantages, and points to their crucial function in nourishing the heart, mind, and overall health throughout life.

Cardiovascular Health Supplements Market Report Scope

Report Attributes Details
Market Size in 2024 USD 11.32 Billion 
Market Size by 2032 USD 20.31 Billion 
CAGR CAGR of 7.62% From 2025 to 2032
Base Year 2024
Forecast Period 2025-2032
Historical Data 2021-2023
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Type (Natural Supplements, Synthetic Supplements)
• By Ingredient (Vitamins & Minerals, Herbs & Botanicals, Omega Fatty Acids, Coenzyme Q10 (CoQ10), Others)
• By Form (Liquid, Tablet, Capsules, Softgels, Powder, Others)
• By Distribution Channel (Offline, Online)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Thermo Fisher Scientific, Agilent Technologies, Shimadzu Corporation, Herbalife Nutrition, Amway, Nature’s Bounty, NOW Foods, GNC Holdings, Nordic Naturals, Bayer, Pfizer, Solgar, Thorne HealthTech, and other players.